5–6 pm Friday, March 8

Cutting Edge Science and Clinical Practice: Buprenorphine/Naloxone for Pain and Opioid Use Disorder (215)

Opioid use disorder (OUD) and pain often co-occur, complicating the treatment of each condition. Research relevant to the use of buprenorphine/naloxone for treatment of patients with opioid use disorder and chronic pain will be presented. Participants will learn about approaches for managing patients with OUD while effectively treating pain.

Opioid Use Disorder Cascade of Care and Adoption of Evidence-Based Practices

Kristen Huntley, PhD

The Role of Buprenorphine When Benefit No Longer Outweighs Harm of Long-Term Opioid Therapy for Chronic Pain

William Becker

Acute and Perioperative Pain Management in Patients Taking Buprenorphine

Andrew A. Herring, MD

Learning Objectives:

  • Understand the complexity of diagnosing OUD in the setting of long-term opioid therapy for pain.
  • Describe appropriate treatment approaches for patients with pain and OUD.
  • Understand best practice strategies for the management of acute and perioperative pain for patients on buprenorphine/naloxone and understand the uses of intravenous buprenorphine for acute and perioperative pain.
5–6 pm Friday, March 8

Obesity and Chronic Pain (213)

Obese patients frequently present with pain complaints and comorbidities that challenge the scope of practice of any single medical specialty. Although the infrastructure for obesity treatment already exists in the realm of pain medicine, the simultaneous management of obesity and chronic pain requires additional office staff and physician training.

Treatment of Chronic Pain in Obese Individuals: Challenges and Solutions

Dmitri Souza, MD PhD

The Aching Fat: Obesity and Chronic Pain

Samer N. Narouze, MD PhD

Learning Objectives:

  • Recognize fundamental relationships between the obesity and chronic pain.
  • Recognize the specifics of interventional and pharmacological management as it applies to obesity and chronic pain.
3:45–4:45 pm Friday, March 8

Pain Management in Athletes: Neurophysiological, Biomechanical, and Psychosocial Considerations (209)

Although pain is common in sport, it is not synonymous with injury. This session will present salient features of the first-ever consensus statement on pain management in athletes. The moderator is first author of this paper and serves as Chief Medical Officer of the National Collegiate Athletic Association.

Pain Management in Athletes Should be Based on the Physiological, Anatomical and Psychosocial Influences on the Individual’s Pain

Brian Hainline, MD

Learning Objectives:

  • Identify neurophysiologic, anatomic and psychosocial influencers of pain in athletes.
  • Distinguish pain from injury in sport.
  • Prescribe appropriate non-pharmacologic and pharmacologic strategies for managing pain in athletes.

Brian Hainline, MD

1:45–2:45 pm Friday, March 8

Addressing Barriers to Effective Pain Care Faced By a Special Population: Clinician, Psychology, and Economic Perspectives (205)

Barriers to effective pain treatment are diverse, undervalued, unidentified and unaddressed, and disproportionately seen in special populations. As a result, chronic-pain remains ineffectively treated and a public-health burden. With evidence and real-world examples, the value of clinicians identifying and addressing the breadth of barriers at the patient level will be presented and discussed from clinical, behavioral-medicine, and health-economic perspectives.

Treatment of Chronic Pain: Public Health and Economic Perspectives for Special Populations

Belinda Udeh

Medical and Interventional Spine: The Barriers to Effective Treatment of Chronic Pain in Special Populations from a Spine Specialist's Perspective

Marzena Buzanowska, MD

Adaptation of a Functional Restoration Program for Special Populations: A Focus on Hispanic Patients with Barriers to Effective Care

Sarah Rispinto, PhD

Learning Objectives:

  • Increase knowledge of the diverse barriers to effective pain treatment faced by special populations, specifically a subset of the Hispanic population, from the physician, psychologist, health economics and public health perspectives.
  • Gain an understanding of the value in addressing these barriers with an Increased confidence to effectively identify and address the patient-specific barriers to effective treatment of pain, specifically those patients from special populations.
  • Increase competence in prescribing treatment plans that maximize effectiveness, by identifying and addressing the patient specific barriers to care.
11 am–Noon Friday, March 8

Oncologic Treatment Related Pain: Updates and Paradigms for Management of Cancer-Treatment Related Pain (201)

Cancer treatment related pain is a small but significant pain population which often present with difficult to treat pain. The treatment algorithms for treating cancer pain are evolving and this session will update the audience to the latest advances in the care of this patient population.

Advanced Therapies for Radiation Induced Neuropathy

Vinay Puttanniah, MD

Treatment Paradigms for Chemotherapy and Immunotherapy Related Pain

Amitabh Gulati, MD

Learning Objectives:

  • Understand the mechanisms of how specific cancer treatments can lead to pain syndromes.
  • Understand the latest advances in treatments for cancer treatment related pain.
3:30–4:30 pm Saturday, March 9

Headache for the Pain Practitioner (316)

Migraine is the second most common type of pain experienced in the US. It is important for the pain provider to understand how to effectively manage this common pain complaint. The goal of this session is to address updates in headache treatment, medically and interventionally for the pain practitioner.

Chronic Migraine: I Have Tried Everything I Know How to Do, Now What?

Meredith J. Barad, MD

Is There a Role for Nerve Blocks in Headache?

Nathaniel Marc Schuster, MD

Cervicogenic Headache: Diagnosis and Treatment

Narayan Kissoon, MD

Learning Objectives:

  • Understand the most up to date treatment recommendations for migraine and the most interesting research from the past year.
  • Understand the role of nerve blocks in headache treatment.
  • Understand the difference between cervicogenic headache and migraine and the treatment differentiations.

Meredith J. Barad, MD


Nathaniel Marc Schuster, MD

Narayan Kissoon, MD

Subscribe to this RSS feed